ChildStats.gov—Forum on Child and Family Statistics
faces of children
Home  |  About the Forum  |  Publications  |  Help
Search

America's Children: Key National Indicators of Well-Being, 2017

Immunization

Data on vaccination coverage are used to identify groups at risk of vaccine-preventable diseases, to provide vaccination coverage estimates in an effort to increase coverage, and to evaluate the effectiveness of interventions designed to increase coverage.

Indicator HC3.A: Percentage of children ages 19–35 months with completed 4:3:1:3*:3:1:4 combined series of vaccinations by poverty status, 2009–2015
Indicator HC3.A: Percentage of children ages 19–35 months with completed 4:3:1:3*:3:1:4 combined series of vaccinations by poverty status, 2009–2015

NOTE: The 4:3:1:3*:3:1:4 series consists of 4 doses (or more) of diphtheria, tetanus toxoids, and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids, and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; the full series of Hib vaccines (3 or 4 doses, depending on product type); 3 doses (or more) of hepatitis B vaccines; 1 dose (or more) of varicella vaccine; and 4 doses (or more) of pneumococcal conjugate vaccines (PCV). Collecting coverage estimates for this combined seven-vaccine series began in 2009 and is part of the HP2020 objectives. The 2009 and 2010 seven-vaccine series estimates were affected by a Hib vaccine shortage, and the interim Advisory Committee on Immunization Practices (ACIP) recommendation suspended the booster dose for healthy children from December 2007 to June 2009, a time when most children in the 2009 National Immunization Survey would have been eligible for the booster dose of the Hib vaccine. The recommended immunization schedule for children is available at http://www.cdc.gov/vaccines/schedules/easy-to-read/child.html.

SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Immunization Survey.

Indicator HC3.B: Percentage of adolescents ages 13–17 with the routinely recommended-for-age vaccinations, 2006–2015
Indicator HC3.B: Percentage of adolescents ages 13–17 with the routinely recommended-for-age vaccinations, 2006–2015

NOTE: Data collection for the 2006 and 2007 survey was only performed during the fourth quarter. The routine recommendation of vaccines for administration beginning with children ages 11–12 include tetanus-diphtheria-acellular pertussis (Tdap) vaccines, meningococcal conjugate (MenACWY) vaccines (1 dose each), and human papillo- mavirus (HPV) vaccines (3 doses). The recommended immunization schedule for adolescents is available at http://www.cdc.gov/vaccines/schedules/easy-to-read/preteen-teen.html.

SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Immunization Survey—Teen.

  • The percentage of children ages 19–35 months who received the recommended combined seven-vaccine series (4:3:1:3*:3:1:4) increased from 69 percent in 2011 to 72 percent in 2015.
  • Children living in families with incomes below the poverty level had a vaccination coverage rate of 69 percent in 2015, compared with 75 percent for children in families with incomes at or above the poverty level.
  • Since 2006, vaccination coverage for adolescents ages 13–17 has increased for all vaccinations routinely recommended for adolescents. Vaccination coverage for one dose (or more) of tetanus, diphtheria, and acellular pertussis (Tdap) and one dose (or more) of meningococcal conjugate (MenACWY) vaccines has increased significantly.
  • For adolescents ages 13–17, vaccination coverage for one dose (or more) of human papillomavirus (HPV) vaccine increased by an average of 5 percentage points annually from 2007 to 2015 for females and by 11 percentage points annually from 2010 to 2015 for males.

table icon HC3A HTML Table | HC3B HTML Table